Cappa, M <br/><br/>
Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome.  [electronic resource] 

 -  Hormone research  1993 
 - 51-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0301-0163 
<br/><br/><label>Standard No.: </label>10.1159/000182695  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Child<br/>Drug Therapy, Combination<br/>Female<br/>Growth Disorders--blood<br/>Growth Hormone--blood<br/>Growth Hormone-Releasing Hormone--administration & dosage<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Obesity--blood<br/>Prader-Willi Syndrome--blood<br/>Pyridostigmine Bromide--administration & dosage